Cargando…
Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease
There is no validated clinical biomarker for disease severity or treatment response for nontuberculous mycobacterial pulmonary disease (NTM-PD). We investigated the correlation between elevated serum carbohydrate antigen (CA) 19-9 levels and NTM-PD disease activity, defined using an imaging severity...
Autores principales: | Kim, Kangjoon, Yong, Seung Hyun, Lee, Su Hwan, Lee, Sang Hoon, Leem, Ah Young, Kim, Song Yee, Chung, Kyungsoo, Kim, Eun Young, Jung, Ji Ye, Park, Moo Suk, Kim, Young Sam, Lee, Hye-Jeong, Kang, Young Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854612/ https://www.ncbi.nlm.nih.gov/pubmed/33531571 http://dx.doi.org/10.1038/s41598-021-82363-5 |
Ejemplares similares
-
The Association between Behavioral Risk Factors and Nontuberculous Mycobacterial Pulmonary Disease
por: Park, Youngmok, et al.
Publicado: (2021) -
Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease
por: Hong, Ji Young, et al.
Publicado: (2015) -
Protective effect of methotrexate on lung function and mortality in
rheumatoid arthritis–related interstitial lung disease: a retrospective cohort
study
por: Kim, Kangjoon, et al.
Publicado: (2022) -
Impact of non-cystic fibrosis bronchiectasis on critically ill patients in Korea: a retrospective observational study
por: Park, Youngmok, et al.
Publicado: (2021) -
The lung microbiota in nontuberculous mycobacterial pulmonary disease
por: Kim, Bo-Guen, et al.
Publicado: (2023)